Clinical variability and probable founder effect in oculocutaneous albinism type 7

Clin Genet. 2020 Mar;97(3):527-528. doi: 10.1111/cge.13655. Epub 2019 Nov 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Albinism, Oculocutaneous / genetics*
  • Albinism, Oculocutaneous / pathology
  • Child
  • Female
  • Founder Effect
  • Genetic Predisposition to Disease*
  • Humans
  • Membrane Proteins / genetics*
  • Pedigree
  • Receptors, LDL / genetics*

Substances

  • IRAG2 protein, human
  • MALRD1 protein, human
  • Membrane Proteins
  • Receptors, LDL